Diversified Trust Co - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Diversified Trust Co ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$136,000
+14.3%
33,2360.0%0.01%
+25.0%
Q4 2021$119,000
-1.7%
33,2360.0%0.00%0.0%
Q3 2021$121,000
-16.6%
33,2360.0%0.00%
-20.0%
Q2 2021$145,000
+5.8%
33,2360.0%0.01%0.0%
Q1 2021$137,000
-6.2%
33,236
-9.3%
0.01%
-16.7%
Q4 2020$146,000
+8.1%
36,656
-26.9%
0.01%0.0%
Q3 2020$135,00050,1790.01%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders